Yasho Industries Ltd Q1 FY2024 Concall Summary

Source transcript PDF: https://assets.stockscans.in/docs/87mrmjfu2kaqqnuwhjpcjmhy.pdf

Key Takeaways


The Q1 Margin Shock

Jhaveri: "I think the Q1 was very much, you can use the word unusual quarter, very much unpredicted, lot of high cost inventories there, unexpected price drop by the competitor of some part of the world and the sentiment, the prices are going down, so that has reduced the margin."

Volume Recovery Underneath the Revenue Decline

Jhaveri: "we believe a kind of sense we are getting today that the pricings have been bottomed out looks like, we see somewhere some start in the certain category and if after the summer vacation which is now going on that is after somewhere in mid-September, we will have more clarity how strongly the..."

The Pakhajan Facility: Timeline and Ramp-Up

Jhaveri: "we are giving guidance we can utilize between 60% and 65% in the capacity as even the Q1 of FY25 will not be a robust, but it will fully ramp up the sales from that facility."

Phase-2 Capex: Gated and Cheaper

Jhaveri: "Once we achieve 70% to 75%, we always think about the next CAPEX, already we have plan in drawing room, but we don't talk about it unless and until we achieve there."

Vapi Operations and the Make-in-India Tailwind


Guidance & Commitments

CommitmentSpecificsTimeline
Margin recovery (Vapi operations)Improvement from subdued Q1 levels, targeting 18% firstH2 FY24
Vapi utilizationAbove 95% of 12,500 MT capacityFY24
Pakhajan trials beginTrials start; no revenue contribution in FY24October/November 2023
Pakhajan commercializationCommercial production beginsEarly FY25
Pakhajan Year 1 utilization60-65% capacity utilizationFY25
Pakhajan optimum utilization90% minimum utilizationFY26 (within 2 years of commercialization)
Long-term consolidated EBITDA margin20%+ minimumOnce optimum utilization at Pakhajan is reached
Phase-2 capex decisionRevisit only after achieving 70-75% utilization at PakhajanBeginning of FY26
Volume breakup disclosureConsumer vs industrial segment breakup in quarterly presentationsStarting next quarter

Key Metrics

MetricQ1 FY24
Revenue from operationsDeclined 16% YoY
Volume growthGrew 6% QoQ (Q4 FY23 to Q1 FY24); declined YoY
EBITDA margin17%-18%, with target to improve to 20% plus
EBITDA per ton~₹1 lakh (per an analyst's math)
Industrial chemicals revenue shareOver 81% of total revenue
Total debt expected by FY24~₹500 cr, including working capital
Phase-1 CAPEX at Pakhajan~₹400 cr, of which ~₹250 cr for land development and long-term CAPEX
Vapi capacity12,500 metric tons
Vapi utilization target for FY24Above 95%
Vapi utilization previous year~90%
New facility utilization target, first year60%-65% (early FY25)
New facility optimum utilization target90% minimum, expected by FY26
New facility commercialization timelineEarly FY25, trials starting October/November
Raw material price decline50% to 100% in some categories